Lnc2Cancer

Experimentally Supported Human LncRNA and Cancer Associations Database

LncRNA centric

Cancer centric

Advanced search

Drug resistant

Circulating

Prognosis

Detail


   LncRNA Name H19
   Synonyms H19, ASM, ASM1, BWS, D11S813E, LINC00008, NCRNA00008, WT2
   Region GRCh38_11:1995176-2001470    Sequence
   Ensembl ENSG00000130600
   RefSeq NR_002196
   Circulating
   Drug-resisitant
   Prognostic
   MiRNA
   Variant
   TF
   Methylation
   Cancer Name thyroid cancer
   ICD-0-3 C73.9  
   Methods qPCR, Luciferase reporter assay etc.
   Sample thyroid cancer tissues, cell lines (TPC-1, NIM, Nthy-ori 3-1 and BCPAP)
   Expression Pattern up-regulated
   Function Description

Our results suggest that H19 functions as a competitive endogenous RNA (ceRNA) by acting as a sink for miR-17-5p, revealing a potential ceRNA regulatory network involving H19 and miR-17-5p with a role in the modulation of YES1 expression. This mechanism may contribute to a better understanding of thyroid cancer pathogenesis and provide new insights into the treatment of this disease.

   Pubmed ID 27093644
   Year 2016
   Title Long noncoding RNA H19 competitively binds miR-17-5p to regulate YES1 expression in thyroid cancer
   External Links
   Links for  H19 GenBank       HGNC       lncrnadb       Noncode
   Links for  thyroid cancer Omim       Cosmic

CopyRight © College of Bioinformatics Science and Technology, Harbin Medical University, China.